Life Sciences, Advanced Cell Technology, Stem Cells
ACT to Vacate Facilities in Boston and California
Ryan McBride 9/10/08
Advanced Cell Technology (OTB:ACTC), a developer of stem cell treatments, says it has not renewed its lease on a facility in Alameda, CA, and has vacated labs in Boston as part of a plan to cut annual operating expenses by $5 million to $6 million. The company maintains operations in Worcester, MA, and in Los Angeles.
Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.
